Down 7.6% currently, Valeant Pharma (NYSE: VRX) is on watch ahead of Bill Ackman's conference call, which is starting at 9:00AM ET.

During the call, Bill Ackman and other members of the Pershing Square investment team will address questions from investors e‐mailed to [email protected].

A live audio webcast of the conference call will be available to the public on PSH's website at www.pershingsquareholdings.com. The conference call will also be available by phone.

US Toll-Free Participant Event Plus Dial-In Number: (844) 489-4527
Participant International Dial-In Number: (925) 418-7826
Conference ID 69916104

This morning Valeant announced it has ended its controversial relationship with Philidor.

Hedge Funds Trader Talk

Valeant Pharmaceuticals (VRX) Bull-Bear Debate RagesOctober 30, 2015 12:57 PM Bill Ackman said Valeant Pharma (VRX) worth $180-$240 Near-Term, $262-$350 Long-TermOctober 30, 2015 10:14 AM Amazon (AMZN) Should Distribute Drugs - AckmanOctober 30, 2015 9:26 AM Pershing Square Valeant Pharma (VRX) Conf. Call Up and Running after Technical DifficultiesOctober 30, 2015 9:14 AM Valeant Pharma (VRX) Appoints Former U.S. Deputy AG Filip to Advise Ad Hoc CommitteeOctober 30, 2015 8:46 AM Evercore ISI's Raffat Provides Thoughts on Valeant Pharma (VRX) October 30, 2015 8:14 AM Former Deputy Attorney General Appointed To Advise Valeant's Ad Hoc CommitteeOctober 30, 2015 8:00 AM Stocks slip but post best month in four years October 30, 2015 7:32 AM BTIG Downgrades Valeant Pharmaceuticals (VRX) to NeutralOctober 30, 2015 6:49 AM Valeant Pharma (VRX) to Sever Ties with PhilidorOctober 30, 2015 5:59 AM